Related Experiment Video
Updated: May 10, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Hypoxic tumor microenvironment in advanced retinoblastoma
Job Sudhakar1, Nalini Venkatesan, Shruthi Lakshmanan
1Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Hypoxia inducible factor-1α (HIF-1α), Carbonic anhydrase IX (CA IX), and survivin are frequently expressed in retinoblastoma (RB). Their deregulation suggests potential therapeutic targets for improving RB treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Retinoblastoma (RB) is a pediatric malignancy with variable therapeutic responses.
- Tumor microenvironment, particularly hypoxia, influences treatment outcomes in various cancers.
- Identifying factors contributing to therapeutic resistance in RB is crucial for improving patient care.
Purpose of the Study:
- To investigate the presence and expression levels of hypoxia and related proteins, including Hypoxia inducible factor-1α (HIF-1α), Carbonic anhydrase IX (CA IX), and survivin, in retinoblastoma tumors.
- To analyze the association between the expression of these markers and clinicopathological features of retinoblastoma.
Main Methods:
- Immunohistochemistry was employed to evaluate the expression of HIF-1α and survivin in 42 retinoblastoma samples and CA IX in 33 samples.
- Tumor samples were categorized based on invasion, differentiation, and International Intraocular Retinoblastoma Classification (IIRC) for correlation analysis.
Main Results:
- High expression rates of HIF-1α (83%), survivin (86%), and CA IX (93%) were observed in retinoblastoma tumors.
- While no significant correlation was found between HIF-1α/CA IX and invasion/differentiation/IIRC groups, increased survivin expression was noted in advanced tumors (Group E vs. D).
- Significant associations were identified between HIF-1α and survivin in both differentiated and undifferentiated tumors, and between HIF-1α and CA IX in tumors with high HIF-1α immunoreactivity.
Conclusions:
- The Hypoxia inducible factor-1α (HIF-1α) pathway appears to be deregulated in retinoblastoma.
- The findings suggest a potential role for these markers in drug resistance.
- Further research is warranted to explore the therapeutic potential of targeting HIF-1α, CA IX, and survivin in retinoblastoma treatment.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
